Ausgabe 5/2021
Inhalt (18 Artikel)
Biology of primary breast cancer in older women beyond routine biomarkers
R. M. Parks, L. H. Alfarsi, A. R. Green, K. L. Cheung
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes
Konstantinos Gasteratos, Antonios Morsi-Yeroyannis, Nikolaos Ch. Vlachopoulos, Georgia-Alexandra Spyropoulou, Gabriel Del Corral, Kongkrit Chaiyasate
Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis
Shinsuke Sasada, Norio Masumoto, Akiko Emi, Takayuki Kadoya, Koji Arihiro, Morihito Okada
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)
Manabu Futamura, Mari Oba, Norikazu Masuda, Hiroko Bando, Morihito Okada, Yutaka Yamamoto, Takanori Kin, Toshiaki Saeki, Takeshi Nagashima, Takashi Kuwayama, Uhi Toh, Akira Hirano, Masafumi Inokuchi, Kazuhiko Yamagami, Yutaka Mizuno, Yasuyuki Kojima, Takahiro Nakayama, Hiroyuki Yasojima, Shinji Ohno
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy
Kenichi Inoue, Norikazu Masuda, Hiroji Iwata, Masato Takahashi, Yoshinori Ito, Yasuo Miyoshi, Takahiro Nakayama, Hirofumi Mukai, Jan-Stefan van der Walt, Joji Mori, Sachi Sakaguchi, Tsutomu Kawaguchi, Yoshinori Tanizawa, Antonio Llombart-Cussac, George W. Sledge Jr, Masakazu Toi
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report
Eijiro Nagasaki, Rei Kudo, Miho Tamura, Kazumi Hayashi, Tadashi Uwagawa, Yoshikazu Kijima, Hiroko Nogi, Hiroshi Takeyama, Masafumi Suzuki, Masako Nishikawa, Shingo Yano, Tadashi Kobayashi
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Ai Amioka, Takayuki Kadoya, Satoshi Sueoka, Yoshie Kobayashi, Shinsuke Sasada, Akiko Emi, Norio Masumoto, Masaoki Ito, Koh Nakayama, Morihito Okada
Correction to: Effect of Wnt5a on drug resistance in estrogen receptor‑positive breast cancer
Ai Amioka, Takayuki Kadoya, Satoshi Sueoka, Yoshie Kobayashi, Shinsuke Sasada, Akiko Emi, Norio Masumoto, Masaoki Ito, Koh Nakayama, Morihito Okada
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)
Christine Song, Val J. Lowe, SeungBaek Lee
Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer
Yayoi Adachi, Isao Oze, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Haruru Kotani, Ayumi Kataoka, Kayoko Sugino, Nanae Horisawa, Yuri Ozaki, Yuka Endo, Kazuki Nozawa, Daiki Takatsuka, Hiroji Iwata
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study
Helle Pappot, Christina W. Baeksted, Aase Nissen, Ann Knoop, Sandra A. Mitchell, Jane Christensen, Niels Henrik Hjollund, Christoffer Johansen
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases
Xue Chao, Wanlin Tan, Julia Y. Tsang, Gary M. Tse, Jintao Hu, Ping Li, Jinghui Hou, Mei Li, Jiehua He, Peng Sun
Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database
Takaaki Konishi, Michimasa Fujiogi, Nobuaki Michihata, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Masahiko Tanabe, Yasuyuki Seto, Hideo Yasunaga
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?
Kazuaki Nakashima, Takayoshi Uematsu, Taiyo L. Harada, Kaoru Takahashi, Seiichirou Nishimura, Yukiko Tadokoro, Tomomi Hayashi, Junichiro Watanabe, Takashi Sugino, Akifumi Notsu
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients
Andrea Villasco, Francesca Accomasso, Marta D’Alonzo, Francesca Agnelli, Piero Sismondi, Nicoletta Biglia
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging
Naoko Mori, Hiroyuki Abe, Shunji Mugikura, Minoru Miyashita, Yu Mori, Yo Oguma, Minami Hirasawa, Satoko Sato, Kei Takase
Comparison of thoracic and abdominal deep inspiration breath holds in whole-breast irradiation for patients with left-sided breast cancer
Kimiko Hirata, Masaru Narabayashi, Yuki Hanai, Kenta Fukumoto, Tomohiro Kosuga, Kazunori Tanaka, Nobutaka Mukumoto, Shuji Ohtsu
Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan”
Akihiko Ozaki, Kazunoshin Tachibana, Tohru Ohtake